ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

LBRX vs SNDX // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

LB Pharmaceuticals Inc (NASDAQ) VS. Syndax Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: LBRX 3 — SNDX 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LBRX VS. SNDX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC LBRX SNDX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -8.40% -35.00% +26.60 LBRX /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -2.72% — — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — 180.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 3/9 -1.00 SNDX /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 54.7 41.2 +13.50 LBRX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.30B $1.26B $31.7M LBRX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR LBRX REV SNDX REV LBRX GROSS % SNDX GROSS % LBRX FCF SNDX FCF
FY 2025 $0 $172.4M — — -$35.3M -$323.2M
FY 2024 $0 $23.7M — — -$53.8M -$274.9M
FY 2023 — $0 — — — -$160.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LBRX // BETA —
SNDX // BETA —